EYE logo

National Vision Holdings Inc. (EYE)

$17.88

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on EYE

Market cap

$1.41B

EPS

0.61

P/E ratio

29.3

Price to sales

0.7

Dividend yield

--

Beta

1.023191

Price on EYE

Previous close

$18.39

Today's open

$18.54

Day's range

$17.70 - $18.54

52 week range

$14.75 - $30.02

Profile about EYE

CEO

L. Reade Fahs

Employees

13411

Headquarters

Alpharetta, GA

Exchange

Nasdaq Global Select

Shares outstanding

79069313

Issue type

Common Stock

EYE industries and sectors

Consumer Discretionary

Retail - Discretionary

News on EYE

Here's Why National Vision (EYE) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

news source

Zacks Investment Research • Aug 17, 2026

news preview

National Vision Stock Down Despite Q2 Earnings & Revenue Beat

EYE beats Q2 earnings and revenue estimates, expands operating margin and raises its 2026 profit outlook despite gross margin pressure.

news source

Zacks Investment Research • Aug 13, 2026

news preview

National Vision Q2 Earnings Call Highlights

National Vision NASDAQ: EYE reported second-quarter 2026 revenue growth and improved profitability as higher average ticket sales and premium product attachment offset lower customer traffic, including temporary disruption from an e-commerce platform transition.

news source

MarketBeat • Aug 12, 2026

news preview

National Vision Holdings, Inc. (EYE) Q2 2026 Earnings Call Transcript

National Vision Holdings, Inc. (EYE) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Aug 12, 2026

news preview

National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results

ALPHARETTA, Ga.--(BUSINESS WIRE)-- #nationalvision--National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its second quarter 2026 results.

news source

Business Wire • Aug 12, 2026

news preview

National Vision (EYE) Surpasses Q2 Earnings and Revenue Estimates

National Vision (EYE) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago.

news source

Zacks Investment Research • Aug 12, 2026

news preview

National Vision (EYE) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for National Vision (EYE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

news source

Zacks Investment Research • Aug 12, 2026

news preview

National Vision Holdings, Inc. Announces Second Quarter 2026 Earnings Release and Conference Call

ALPHARETTA, Ga.--(BUSINESS WIRE)-- #nationalvision--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its second quarter 2026 financial results before the market opens on Wednesday, August 12, 2026, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the “Investors” section of the Company's website at https://ir.nationalvision.com. A live audio webcast of the confer.

news source

Business Wire • Jul 29, 2026

news preview

Allspring Common Stock Fund Q2 2026 Fund Performance And Attribution

The Allspring Common Stock Fund outperformed the Russell 2500 Index during the second quarter, driven primarily by allocation decisions, with security selection also contributing positively. Health care was the largest contributor to relative results, driven by strong stock selection across several holdings. Conversely, consumer discretionary detracted from results, driven primarily by weakness within the specialty retail industry.

news source

Seeking Alpha • Jul 21, 2026

news preview

Rise Nano Optics Announces Strategic Partnership with SportifEye Optics to Produce and Commercialize SpectraGuard(TM) Lenses in the United States

Expanding Lab Partnership Network now includes expertise in Sport, Safety and Performance Eyewear Vancouver, British Columbia--(Newsfile Corp. - June 24, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced a strategic partnership with SportifEye Optics ("SportifEye"), a cutting-edge, full-service optical laboratory and VSP®-Authorized Lab based in Southern California, to support the production and commercialization of its SpectraGuard lens technology in the United States.

news source

Newsfile Corp • Jun 24, 2026

news preview

¹ Disclosures

Get started with M1

Invest in National Vision Holdings Inc.

Open an M1 investment account to buy and sell National Vision Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in EYE on M1